NeoGenomics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
NeoGenomics, Inc. (NEO) reported Increase (Decrease) in Prepaid Expense and Other Assets of $2.85 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-07-28
- NeoGenomics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $1.46M.
- NeoGenomics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $1.40M, a 55.07% decline year-over-year.
- NeoGenomics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$3.21M, a 156.98% decline year-over-year.
- NeoGenomics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $514.00K, a 66.23% decline year-over-year.
- NeoGenomics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$1.55M, a 122.76% decline from fiscal 2024.
- NeoGenomics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $6.83M, a 114.81% increase from fiscal 2023.
- NeoGenomics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $3.18M, a 174.14% increase from fiscal 2022.
- NeoGenomics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $1.16M, a 39.14% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | $2.85M 10-Q · filed 2026-07-28 | -$353.00K derived: sum of 3 quarters · filed 2026-07-28 | $161.00K derived: sum of 4 quarters · filed 2026-07-28 |
| 2026-03-31 | $1.40M 10-Q · filed 2026-04-28 | -$1.81M derived: sum of 2 quarters · filed 2026-04-28 | -$1.30M derived: sum of 3 quarters · filed 2026-04-28 | -$3.27M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-12-31 | -$3.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$2.69M derived: sum of 2 quarters · filed 2026-02-17 | -$4.66M derived: sum of 3 quarters · filed 2026-07-28 | -$1.55M 10-K · filed 2026-02-17 |
| 2025-09-30 | $514.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$1.46M derived: sum of 2 quarters · filed 2026-07-28 | $1.65M 10-Q · filed 2025-10-28 | $7.28M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-06-30 | -$1.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | $1.14M 10-Q · filed 2026-07-28 | $6.76M derived: sum of 3 quarters · filed 2026-07-28 | $8.28M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-03-31 | $3.10M 10-Q · filed 2026-04-28 | $8.73M derived: sum of 2 quarters · filed 2026-04-28 | $10.25M derived: sum of 3 quarters · filed 2026-04-28 | $7.96M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $5.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $7.15M derived: sum of 2 quarters · filed 2026-02-17 | $4.86M derived: sum of 3 quarters · filed 2026-02-17 | $6.83M 10-K · filed 2026-02-17 |
| 2024-09-30 | $1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$770.00K derived: sum of 2 quarters · filed 2025-10-28 | $1.21M 10-Q · filed 2025-10-28 | -$779.00K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | -$2.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$316.00K 10-Q · filed 2025-07-29 | -$2.30M derived: sum of 3 quarters · filed 2026-02-17 | $250.00K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $1.98M 10-Q · filed 2025-04-29 | -$9.00K derived: sum of 2 quarters · filed 2026-02-17 | $2.54M derived: sum of 3 quarters · filed 2026-02-17 | $3.97M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | -$1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $566.00K derived: sum of 2 quarters · filed 2026-02-17 | $1.99M derived: sum of 3 quarters · filed 2026-02-17 | $3.18M 10-K · filed 2026-02-17 |
| 2023-09-30 | $2.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $3.98M derived: sum of 2 quarters · filed 2024-11-05 | $5.17M 10-Q · filed 2024-11-05 | $2.72M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $2.61M 10-Q · filed 2024-07-30 | $169.00K derived: sum of 3 quarters · filed 2025-02-18 | $1.57M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $1.19M 10-Q · filed 2024-04-30 | -$1.26M derived: sum of 2 quarters · filed 2025-02-18 | $145.00K derived: sum of 3 quarters · filed 2025-02-18 | $303.00K derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | -$2.44M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | -$1.04M derived: sum of 2 quarters · filed 2025-02-18 | -$884.00K derived: sum of 3 quarters · filed 2025-02-18 | $1.16M 10-K · filed 2025-02-18 |
| 2022-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $1.56M derived: sum of 2 quarters · filed 2023-11-06 | $3.60M 10-Q · filed 2023-11-06 | -$6.29M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $158.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $2.20M 10-Q · filed 2023-08-08 | -$7.69M derived: sum of 3 quarters · filed 2024-02-20 | -$573.00K derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $2.04M 10-Q · filed 2023-05-09 | -$7.85M derived: sum of 2 quarters · filed 2024-02-20 | -$731.00K derived: sum of 3 quarters · filed 2024-02-20 | $3.16M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | -$9.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | -$2.77M derived: sum of 2 quarters · filed 2024-02-20 | $1.11M derived: sum of 3 quarters · filed 2024-02-20 | $1.91M 10-K · filed 2024-02-20 |
| 2021-09-30 | $7.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $11.00M derived: sum of 2 quarters · filed 2022-11-08 | $11.80M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $3.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $4.68M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $794.00K 10-Q · filed 2022-05-09 | |||
| 2020-09-30 | $782.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $7.01M derived: sum of 2 quarters · filed 2021-11-04 | $6.76M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $6.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $5.97M 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | -$254.00K 10-Q · filed 2021-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |